Terminalia aquna (T. aduna) stem bark was successively extracted with petroleum ether (A), solvent ether (B), ethanol (C) and water (D). The lipid lowering activity of these four fractions A, B, C, and D was evaluated in vivo in two models viz., triton WR-1339 induced hyperlipemia in rats as well as fructose rich high fat diet (HFD) fed diabetic-dyslipidemic hamsters. Hyperlipidemia induced by triton caused marked increase in the plasma levels of total cholesterol (-Fc), triglyceride (Tg) and phospholipids (PL) in rats. After treatment with T. a~una fractions A, B, C, and D at the doses of 250 mg/kg per oral (p.o.), only the ethanolic fraction (C) exerted significant lipid lowering effect as assessed by reversal of plasma levels of Tc, Tg and PL in hyperlipidemic rats. In another experiment, feeding with HFD produced marked dyslipidemia as observed by increased levels of plasma Tc, Tg, glucose (Glu), glycerol (Gly) and free fatty acids (FFA) in hamsters. After treatment with T. arjuna fractions at the doses of 250 mg/kg p.o. only two fractions (B and C) could exert significant lowering in the plasma levels of lipids and Glu. in dyslipidemic hamsters. In vitro experiment T. arjuna fractions at tested concentrations (50-500 pg/ml) inhibited the oxidative degradation of lipids in human low density lipoprotein and rat liver microsomes induced by metal ions. These fractions when tested against generation of oxygen free radicals at the concentrations (50-500 iglml), counteracted the formation of superoxide anions (0 2) and hydrodyl radicals (OH) in non enzymic test systems. The efficacy of T. a~una fractions as antidysiipidemic and antioxidant agents was found, fraction C> fraction B> fraction A.
INTRODUCTION
The bark of Terminalia arjuna (family Combretaceae) is one such Ayurvedic remedy that has been mentioned in many ancient Indian medicinal literature including Charaka Samhita and Astang Hridayam, to possess cardio protective property (1) . It is an essential ingredient of many potent Ayurvedic preparations sold as cardiotonics (2) . The plant is found in plenty throughout Indo sub Himalayan tracts of Uttar Pradesh, South Bihar, Madhya Pradesh, Delhi, Deccan region mainly along riverside, riverlets and ponds. A number of experimental and clinical studies have proved that dried bark powder of this plant have potent hypolipidemic and cardioprotective activity (3) (4) (5) (6) (7) . The bark powder of T. aquna has also been found to improve antioxidant status in the patients of coronary heart disease and these beneficial effects may be related to its high flavonide content (8) . It has been well documented that bark extract contains acids (arjunic acid, terminic acid), glycosides (argentine arjunosides I-IV), strong antioxidants (flavones, tannins, oligomeric proanthocyanidins), minerals etc, but not much is known about the specific biological activity of individual constituents of this plant. Few of the active compounds from T. aouna bark have been isolated and shown to possess antimutagenic and anticarcinoginic activity (9, 10) . Arjunolic acid, a new triterpene isolated from the bark of T. atjuna have been reported to have antioxidant and cardioprotective activity (11) . But the fraction type of T. arjuna bark extract having the high degree of antioxidant and antidyslipidemic activity is not well known. Therefore the present study has been undertaken to evaluate the antidyslipidemic activity of different solvent fractions of bark extract of T. ar]una bark powder in tdton and high fat diet (HFD) fed hamster model. The antioxidant activity of these fractions was also evaluated by generating free radicals in vitro in the absence and presence of T. aouna fractions.
MATERIALS AND METHODS

Preparation of fractions of T. arjuna
Fresh T. arjuna stem bark was collected, identified pharmacognostically in the Botany division of the Institute. Bark powder of T. arjuna was successively extracted with petroleum ether (fraction-A), solvent ether (fraction-B), alcohol (fraction-C) and aqueous (fraction-D) as described by Row et al. (12) . These fractions were used for in vivo and in vitro studies.
Animals
Rats (Charles Foster strain, male, adult, body wt 200-225 g) and hamster (Golden Syrian, male, adult, body wt. 120-130 g) were kept in a room with controlled temperature at 25-26~ humidity 60-80% and 12/12 hours light/dark cycle (light on from 8.00 AM to 8 PM) under hygienic conditions. Animals were acclimatised for one week before starting the experiment. The animals had free access to the normal diet and water.
Lipid lowering activity in Triton induced hyperlipidemic rat model Rats were divided into six groups-control, triton induced, triton plus 7". arjuna fractions A, B, C and D treated groups containing six animals in each group. In the acute experiment of 18 hours, hyperlipidemia was developed by administration of triton WR-1339 (Sigma Chemical Company, St. Louis, MO, USA) at a dose of 400 mg/kg, b,w. intraperitonea]ly to animals of all the groups except the control. T. arjuna fractions were macerated with gum acacia, suspended in water and fed simultaneously with tdton at a dose of 250 mg/kg p.o. to the animals of T. arjuna fractions treated groups and diet was withdrawn.. Animals of control and triton group without treatment with 7. aduna fractions were given same amount of gum acacia suspension (vehicle). After 18 hours of treatment the animals were anaesthetised with thiopentone solution (50 mg/kg b.w.) prepared in normal saline and l ml blood was withdrawn from retro-orbital sinus using glass capillary in EDTA coated eppendorf tubes (3.0 mgtml blood). The blood was centrifuged at 2500 x g for 10 minutes at 4~ and plasma was separated. Plasma was diluted with normal saline in a ratio of 1:3 and used for the analysis of total cholesterol (T-chol), triglycedde 0"g) and phospholipid (PL) by standard enzymatic methods (13, 14, 15) w/w), cholesterol (0.45% w/w), powdered hamster chow diet (64% w/w) and coconut oil (26% w/w). Hamsters were divided into six groups -control, HFD fed, HFD fed and 7". arjuna fraction-A, B, C and D treated groups containing eight animals in each. HFD (9.0g / animal) was given daily from day1 to day 10 to animals of all the groups except control. Animals had free access to the diet and the daily diet consumed by animals was calculated by subtracting the left over diet on next day from the added diet on previous day. Control group received the normal hamster chow. T. arjuna fractions were given orally at a dose of 250 mg/kg b.w. once a day from day 4 to day 10 to all groups except the animals of control and HFD fed group, to them same amount of vehicle ( as mention above) was given. Body weight of animals was recorded daily. On tenth day, two hours after the dosing, animals were anaesthetised and blood was collected in EDTA coated eppendorf tubes as well as in an another similar tube (EDTA coated) having 120 ml of NaF solution (45 mg/ml). The blood was centrifuged at 2500xg rpm for 10 minutes at 4~ and plasma was separated. Plasma without NaF solution was used for the analysis of T-chol (13), Tg (14) and HDL-cholesterol (HDL-chol) (16) and the plasma with NaF solution was used for the analysis of glucose (Glu), glycerol (Gly) and fatty acids (FFA) by standard enzymatic methods (16, 17, 18, 19 ) using auto-analyser. All assay kits except of FFA were purchased from Beckman Coulter International, USA and assay Kit for FFA was purchased from Wako Pure Chemical Industries Ltd., Osaka Japan.
Antioxidant activity LDL oxidation : Serum was separated from the blood of normolipemic donors who were fasted overnight and fractionated into very low-density lipoprotein (VLDL), low density lipoprotein (LDL) and high density lipoprotein (HDL) by ultracentrifugation (20) . The lipoproteins preparations were dialysed Indian Journal of Clinical Biochemistry, 2004, 19 (2) against 150 mM NaCI containing EDTA (0.02 % w/ v) in presence of N 2 gas in cold. The purity of LDL was checked on polyacrylamide gel electrophoresis. LDL (0.71 mg) and CuCI2.2H20 (10 pM) in the absence or presence of 7. arjuna fractions A, B, C and D (50-500 pg/ml) in 50 mM phosphate buffer saline (pH 7.4) to a final volume of 1.5 ml, was incubated at 37~ for 16 hours. The level of lipid peroxides in unoxidised LDL, oxidised LDL with Cu * § in the absence or presence of T. arjuna fractions was assayed (21) as thiobarbuteric acid reactive substances (TBARS). Briefly the reaction mixture contained 0.5ml SDS (8% w/v), 0.5 ml glacial acetic acid, 1.5 ml TBA (0.8% w/v) was heated in a boiling water bath for one hour. After cooling upto room temperature optical density of reaction mixture was read at 532 nm with respective reagent blank. The level of lipid peroxide as n mol of malondialdehyde formed was calculated by taking absorption Coefficient of MDA as 1.78 xl0 s cm 1 M 1 mg protein.
Lipid peroxidation in Mlcrosomes : Lipid peroxidation in microsomes was induced by nonenzymic reactants (22) . Briefly rat liver microsomes (protein 2.0 mg), FeSO4.7H20 (2 pM) and sodium ascorbate (10 pM) in absence or presence of 7-. arjuna fractions (50-500 mg/ml) in 100 mM phosphate buffer, pH 7.8 to a final volume of 2 ml were incubated at 37~ for 90 minutes. Reference tubes and reagent blank were also run simultaneously. After incubation, all the sets were ~ssayed for lipid peroxide content by their reaction with thiobarbituric acid as mentioned above (21) . The lipid peroxide content in microsomes was expressed as n mol. MDA formed/mg protein.
Generation of oxygen free radicals -Superoxide anions (0 -2) were generated enzymatically (23) by xanthine (160 mM), Xanthine oxidase (0.04 units) and Nitroblue tetrazolium (320 pM) in absence or presence of T. arjuna bark fractions (50-500 pg/ ml) in 100 mM phosphate buffer (pH 8.2). Fractions were sonicated well in phosphate buffer before use. The reaction mixture was incubated at 37~ After 30 minutes the reaction was stopped by adding 0.5 ml glacial acetic acid and the amount of formazone formed was measured at 560 nm on a spectrophotometer.
Percentage inhibition was calculated taking absorption coefficient of formazone as 7.2x10 z M 1 cm ~. In another set of experiment, effect of 7". aduna fractions on generation of hydroxyl radicals (OH-) was also studied by nonezymic reactants (24) . Briefly OH were generated in a non-enzymic system comprised of deoxyribose (2.8 mM), FeSO4.7H20 (2 mM), Sodium ascorbate (2.0 mM) and H=O= (2.8 mM) in 50 mM KH2PO 4 buffer, pH 7.4 to a final volume of 2.5 mt. The above reaction mixtures in the absence or presence
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141-148 of T. ar]una bark fractions (50-500 mg/ml) were incubated at 37~ for 90 minutes. Reference tubes and reagent blanks were also run simultaneously. Malondialdehyde (MDA) content in both experimental and reference tubes were estimated spectrophotometrically by thiobarbuteric acid method as mentioned above (21) .
Statistical evaluation
Data were analysed using student's t-test. The hypertil~idemic groups were compared with control and T. arujna fractions treated groups. Similarly the generation of oxygen free radicals and lipid peroxidation in LDL and microsomes with different fractions of T. arjuna were compared with that of their formation without fractions. P<0.05 was considered to be significant.
RESULTS
Effect of T arjuna fractions on hyperlipidemia
Administration of triton WR-1339 in rats induced marked hyperlipidemia as evidenced by increase in the plasma levels of Tc (5.90 fold), Tg (4.59 fold) and PL (7.89 fold) as compared to control ( Table 1) . Treatment of hyperlipidemic rats with T. arjuna fractions A, B, C and D at the dose of 250 mg/Kg p.o. reversed the plasma levels of lipid but with varying extents. The effect of ethanolic fraction (fraction C), causing a decrease in plasma levels of Tc, Tg and PL by 31, 40 and 18% respectively as compared to triton was more significant than other fractions. The order of lipid lowering activity by these fractions in above model was fraction C> fraction D> fraction B> fraction A (Table 1) . In another experiment dyslipidemia in hamster was produced by feeding them with fructose rich HFD. The plasma levels of Tg, Tc, HDL-chol, glucose, glycerol and FFA of these animals were found to be elevated by 106, 300, 30, 54, 30 and 87% respectively as compared to control. Administration of T. arjuna fractions at the dose of 250 mg/Kg p.o. simultaneously with HFD in hamsters lead to Iowedng in the plasma levels of lipid and the effects of fraction B (solvent ether) and that of fraction C (ethanol) were more pronounced as these animals were observed with decrease in levels of Tg (28 and 28%), Tc (37-48%) and glycerol (34 and 39%) respectively as compared to dyslipidemic group Table 2 ). HFD caused increase in the plasma level of HDL-chol. which was further increased (20%) after treatment with 7". aquna fraction C (ethanol) but other fractions failed to shown any significant increase in above parameter in dyslipidemic hamster. Furthermore HFD caused increase in the level of plasma glucose by 54% as compared to (Table 3) . Addition of T. arjuna fractions (50-500 pg/ml) inhibited the Cu §247 mediated lipid peroxidation of LDL in concentration dependent manner. At peak levels of 500 pg/ml, the fraction A, B, C or D inhibited LDL peroxidation by 22, 76 79 and 31% respectively. It was also observed that normal rat liver microsomes containing 3.17 + 0.35 n mol MDA/mg protein, when challenged with the reactions (Fe*2-sodium ascorbate) employed in nonenzymic system for peroxidation, increased the levels of lipid peroxides by 2.0-2.5 folds (Table 3) . Addition of 7". arjuna fractions (50-500 pg/ml) in above system made microsomes less susceptible against oxidative degradation of their lipids and at peak concentration of 500 pg/ml fraction A, B, C or D could protect peroxidation in microsomes by 20, 45, 50 and 13% respectively (Table 3) . Furthermore, the scavenging potential of T. aquna fractions at 50-500 ig/ml against formation of 02 and OH in non enzymic systems were also studied ( Table 3 ). The significant decrease in supei'oxide anions (27 and 70%) by fraction A (petroleum ether) and fraction C (ethanol) and hydroxyl radicals (17, 41, 40 and 19%) by fractions A,B,C or D was found at concentrations of 500 pg/ml. Solvent ether and ethanolic fraction (fraction B and C ) of T. aouna showed more antioxidant activity in above test systems as compared to that of fractions A and D.
DISCUSSION
The involvement of hydroxyl free radicals (OH) is a major causative factor for peroxidative damage to lipoproteins, which is responsible for initiation and progression of atherosclerosis in hyperlipidemic subjects (25) . Hyperlipidemia may also induce abnormalities with oxidation of fatty acids leading to the formation of ketone bodies as well as making liver and muscle resistance to insulin which initiate and progress diabetes in patients (26) . Furthermore, due to hyperglycaemia, increase in non enzymic glycosylation occurs, accompanied with glucose oxidation and these reactions are catalysed by Cu *z and Fe .2, resulting in formation of 02 and OH-radicals which further accelerates the risk of cardiac diseases in dyslipidemia (27) .
To overcome these ailments, a drug having multifold properties such as lipid lowering, antidiabetic and antioxidant activities together is in great demand. T. arjuna bark have been reported earlier to possess both the lipid lowering and antioxidant activities. In the present study, we have investigated these properties in different solvent fractions of this plant material and attempted to isolate active fraction (s) and effective molecules. Both solvent ether and ethanolic fractions (fraction B and C) caused significant decrease in the plasma levels of lipids in triton as well as in HFD fed models of hyperlipidemia. Triton WR-1339 acts as surfactant, suppresses the action of lipases and block the uptake of lipoprotiens from circulation by extrahepatic tissues resulting in an increase in the levels of circulatory lipid (28) . These test samples inhibited cholesterol biosynthesis and potentiated the activity of lipolytic enzymes to early clearance of lipids from circulation in triton-induced hyperlipidemia. We have successfully used this model for evaluation of lipid lowering activity of T.aquna bark and other natural products (4). We have employed HFD induced diabetes-dyslipidemia in hamster, which is a very suitable model for screening of drugs for the regulation of lipid and carbohydrate matabolism (29, 30) . Feeding with solvent ether and ethanolic fractions of T.atjuna exhibited lowering of plasma lipids and glucose, suggesting that this property of test samples is mediated through peroxisomes proliferater activated receptor-~ subtype (PPAR~) in diversified manner by catabolizing Tg, upregulating lipoprotein lipases to rid off dietary load, and improve the HDL levels for the maintenance of lipid-glucose homeostasis in hamster model (31, 32) .
To assess the antioxidant activity of T. atjuna fractions, we have used Cu~2/ Fe *z induced LDL and rat liver microsomes for oxidation as in vitro model of nonenzymic stimulation of lipid peroxidation mediated by the action of OH radicals (33, 34) . In the present study solvent ether and ethanolic fractions of 7". arjuna inhibited the peroxidative degradation of LDL and microsomal lipids as well as suppressed the generation of OH radicals in above tests. These properties of the fractions as antioxidant and scavenger of oxygen free radicals appears to be mediated through activity like metal ion chaelators and xanthine oxidase inhibitors (34).
We have followed the extraction procedure as described by Row et al. (12) biotransformation through hepatic drug metabolising cascade, produce common active molecules which may be responsible for lipid lowering activity in vivo. The quantity of arjunic acid in solvent ether fraction was comparatively very less than those of its derivative in ethanolic fraction and due to this, at the same doses ethanolic fraction was more effective than solvent ether fraction. More work on drug metabolism and to assess the biological activity in vivo and in vitro of T. arjuna fractions is under progress to substantiate the findings.
